Patents Assigned to University of Dundee
  • Publication number: 20170342036
    Abstract: The present invention relates to the discovery that salt inducible kinases (SIKs) suppress the formation of anti-inflammatory molecules such as IL-10, which are important for the resolution of inflammation and identifies SIK inhibitors that may be used to treat disorders associated with undesirable inflammation, such as inflammatory bowel disease and/or autoimmune disorders.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Applicants: Dana-Farber Cancer Institute, Inc., University Court of the University of Dundee
    Inventors: Philip Cohen, Kristopher Clark, Hwan Geun Choi, Nathanael S. Gray
  • Patent number: 9828346
    Abstract: The present invention relates to N-heterocyclic sulphonamide compounds, in particular pyrazole sulphonamide compounds, and their use as N-myristoyl transferase inhibitors.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: November 28, 2017
    Assignee: University of Dundee
    Inventors: Stephen Brand, Paul Wyatt, Stephen Thompson, Victoria Smith, Tracy Bayliss, Justin Harrison, Neil Norcross, Laura Cleghorn, Ian Gilbert, Ruth Brenk
  • Patent number: 9801655
    Abstract: A device for creating an intercostal transcutaneous access to an, in particular endoscopic, operating field including a base body, which closely surrounds an incision all-side frame-shaped and with at least two webs mounted on the base body, which can be introduced into an intercostal space, by which two ribs arranged next to each other can be moved apart. To create a device for creating an intercostal transcutaneous access to an, in particular endoscopic, operating field which allows individual pressing apart of the ribs, it is proposed according to the invention that the at least two webs are mounted adjustable relative to each other on the base body.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: October 31, 2017
    Assignee: University of Dundee
    Inventors: Alfred Cuschieri, Stuart Coleman, Duncan Martin
  • Patent number: 9670165
    Abstract: The present invention relates to the discovery that salt inducible kinases (SIKs) suppress the formation of anti-inflammatory molecules such as IL-10, which are important for the resolution of inflammation and identifies SIK inhibitors that may be used to treat disorders associated with undesirable inflammation, such as inflammatory bowel disease and/or autoimmune disorders.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: June 6, 2017
    Assignees: Dana-Farber Cancer Institute, Inc., University Court of the University of Dundee
    Inventors: Philip Cohen, Kristopher Clark, Hwan Geun Choi, Nathanael Gray
  • Patent number: 9585550
    Abstract: There is disclosed medical apparatus of the type for use in surgery such as transanal endoscopic microsurgery, as well as methods of providing access to, inspecting and enabling surgery within a body passage. In one embodiment of the invention, medical apparatus in the form of a rectal expander (10) is disclosed, the expander (10) being adapted for location at least partly within a body passage such as the rectum (12) of a patient (14), the expander (10) having a leading end (18) and an access area in the form of an opening (20) for access from the expander (10) into the rectum (12), at least part of the opening (20) being spaced from the leading end (18), and the expander (10) being controllably movable between collapse and expansion positions, for expanding the rectum (12).
    Type: Grant
    Filed: June 24, 2004
    Date of Patent: March 7, 2017
    Assignee: University of Dundee
    Inventors: Eric Abel, James R. Hewit, Alan P. Slade, Zhigang Wang
  • Publication number: 20170051729
    Abstract: An actuator (12) includes a moving member (18) pivotally connected to a base unit (14) for rotation about an axis. The driving force for rotation of the moving member (18) relative to the base unit (14) is provided by a pair of antagonistically operating shape memory alloy (SMA) wires (48, 50) and transmitted via a torsional spring (56). An endoscope, or a snake-like robot (66), may include one or more of the actuators (12).
    Type: Application
    Filed: April 23, 2015
    Publication date: February 23, 2017
    Applicant: University of Dundee
    Inventors: Luigi Manfredi, Alfred Cuschieri
  • Publication number: 20170050881
    Abstract: A method for welding together glass workpieces where one of the workpieces has metal nanoparticles positioned at or near the surface to be welded. The method comprises positioning the workpieces in operative contact at an interface where a weld is to be formed, applying a laser beam to be incident upon the interface wherein energy from the laser beam is absorbed by the nanoparticle bearing workpiece and the energy from the laser beam is transferred to the glass surrounding the metal nanoparticles to heat the glass and to weld the workpieces together.
    Type: Application
    Filed: January 27, 2015
    Publication date: February 23, 2017
    Applicant: The University of Dundee
    Inventor: Amin Abdolvand
  • Patent number: 9454060
    Abstract: A mode locked semiconductor disk laser with an output beam having an ultra-short pulse length which provides the incident beam to a non linear microscope. The wavelength of the beam is at or near the action cross section maximum absorption wavelength for creating two photon excited fluorescence of a fluorescent biological marker in a sample. Semiconductor disk lasers combine excellent beam quality and output power, stability while maintaining simplicity and easiness of operation. In addition, these types of lasers are ideally suited for mass production as they are built in wafer-scale technology enabling a high level of integration. Importantly this non expensive, turn-key, compact laser system could be used as a platform to develop portable non-linear bio-imaging devices for clinical studies, facilitating its wide-spread adoption in “real-life” applications.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: September 27, 2016
    Assignee: The University of Dundee
    Inventors: Craig Hamilton, Graeme Malcolm, Ursula Keller, Thomas Sudmeyer, Kurt Weingarten, Pablo Loza-Alvarez, Yohan Barbarin, Edik Rafailov
  • Patent number: 9365508
    Abstract: The invention provides compounds according to formula (I): (wherein X, Y, Z1 R1, R2, R3, Ar and Ar? are as defined herein), and physiologically acceptable salts, solvates, esters or amides thereof, pharmaceutical compositions comprising these compounds and the compounds for use in medicine, for example for the treatment or prophylaxis of diseases involving cell proliferation, such as cancer, and for the treatment or prophylaxis of other diseases.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: June 14, 2016
    Assignees: University Court of the University of St Andrews, University Court of the University of Dundee
    Inventors: Sonia Lain, Nicholas James Westwood, David Philip Lane
  • Publication number: 20160095823
    Abstract: The present invention concerns compounds derived from the anaesthetic propofol that are useful as analgesics and methods of using the same. The compounds act as co-activators of strychnine-sensitive glycine receptors and may have greater activity at those glycine receptors than at GABAA.
    Type: Application
    Filed: November 24, 2015
    Publication date: April 7, 2016
    Applicants: The University of Liverpool, The University of Dundee, Medizinische Hochschule Hannover
    Inventors: Martin Leuwer, Gertrud Haeseler, Jeremy Lambert, Delia Belelli
  • Patent number: 9265826
    Abstract: The present invention relates to agents capable of binding sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) and their use in the treatment of cell proliferation and differentiation disorders. Furthermore, the present invention provides associated pharmaceutical formulations and methods.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: February 23, 2016
    Assignee: University Court of the University of Dundee
    Inventors: Paul Richard Crocker, Bjoern Biedermann, David Bowen
  • Publication number: 20160000908
    Abstract: The present invention relates to agents capable of binding sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) and their use in the treatment of cell proliferation and differentiation disorders. Furthermore, the present invention provides associated pharmaceutical formulations and methods.
    Type: Application
    Filed: March 12, 2013
    Publication date: January 7, 2016
    Applicant: University Court of the University of Dundee
    Inventors: Paul Richard Crocker, Bjoern Biedermann, David Bowen
  • Patent number: 9229939
    Abstract: A system for arranging searchable items, such as digital images or multimedia icons for presentation on a graphical user interface. The system has an optimizer module which minimizes a cost function for arranging items in a layout space and is applied to one or more predetermined characteristics of the items. The optimizer module also creates a mixture distribution by considering each item as having a spatial distribution in the layout space and controls the entropy of the mixture distribution in order to maximize the extent to which each item occupies a separate position in the layout space. A Renderer module then renders the layouts to generate a display.
    Type: Grant
    Filed: January 28, 2010
    Date of Patent: January 5, 2016
    Assignee: The University of Dundee
    Inventors: Stephen McKenna, Ruixuan Wang, Annette Ward
  • Patent number: 9155289
    Abstract: Non-human animals which overexpress PPARd or which express transgenic PPARd are useful as models for inflammatory skin conditions such as psoriasis. Test substances can be screened to assess their suitability for the treatment of inflammatory skin conditions such as psoriasis. Methyl 3-({[2-(methoxy)-4-phenyl]amino}sulfonyl)-2-thiophenecarboxylate can be administered topically for the prevention or treatment of psoriasis.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: October 13, 2015
    Assignee: University Court of the University of Dundee
    Inventors: Colin Palmer, John Foerster, Nainamalai Sitherswaran
  • Patent number: 9120765
    Abstract: The present invention relates to compounds which activate the p53 response, and find use in, for example, hyperproliferative diseases such as cancer treatment and potentially other diseases/conditions involving sirtuin function.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: September 1, 2015
    Assignees: University Court of the University of Dundee, University Court of the University of St. Andrews
    Inventors: Sonia Lain, David Phillip Lane, Michael John Raymond Stark, Anna Rose McCarthy, Jonathan James Hollick, Nicholas James Westwood
  • Patent number: 9101345
    Abstract: A surgical tissue anchor comprising a plurality of jaws suitable for clamping onto tissue, clamp component(s) operable to bias the jaws in a closed position and attachment structure operable for attachment of the anchor to one or more tethers for retracting the clamped tissue. The one or more tethers are guided to the desired region using a surgical guide.
    Type: Grant
    Filed: January 19, 2012
    Date of Patent: August 11, 2015
    Assignee: The University of Dundee
    Inventors: Stuart Ian Brown, Stuart Coleman, Alfred Cuschieri, Leslie Kelly, Paul Simon Maher, James Duncan Shaw Martin
  • Patent number: 9079895
    Abstract: The invention relates to morpholino-derivatives according to Formula (I) or stereoisomers or pharmaceutically acceptable salts or solvate thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, m and n are as defined in the specification. The compounds are antagonists, reverse agonists or agonists of G-protein coupled receptors, such as dopamine D4 and 5HT1a. The inventions also relates to pharmaceutical compositions comprising the compounds and methods involving the compounds and compositions. The compounds and compositions of the invention may in particular be used in the treatment of diseases and disorders, such as neurological and neurodegenerative diseases; or as lead compounds for the design and selection of further therapeutic compounds.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: July 14, 2015
    Assignee: University of Dundee
    Inventors: Jeremy Besnard, Andrew Lee Hopkins, Ian Gilbert, Gian Filippo Ruda, Keren Abecassis
  • Patent number: 9068165
    Abstract: The present invention provides methods and compositions for modulating cell senescence and cell proliferation using isoforms of the p53 tumor suppressor protein. The methods and compositions of the invention find use in inhibiting cancer cell growth or in generating populations of cells for tissue regeneration through the modulation of cell senescence and proliferation.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: June 30, 2015
    Assignees: The United States of America as represented by the Secretary of the Department of Health and Human Services, The University of Dundee, Masaryk Memorial Cancer Institute
    Inventors: Curtis C. Harris, Kaori Fujita, Izumi Horikawa, Borivoj Vojtesek, Jean-Christophe Bourdon, David P. Lane
  • Publication number: 20150104806
    Abstract: The present invention relates to a biomarker for Parkinson's disease. The biomarker and products associated with the biomarker may be used to assist diagnosis or to assess onset and/or development of Parkinson's disease. The invention also relates to use of the biomarker in clinical screening, assessment of prognosis, evaluation of drug treatments, drug screening or drug development in the field of Parkinson's disease and Parkinson's disease related disorders.
    Type: Application
    Filed: April 10, 2013
    Publication date: April 16, 2015
    Applicant: University of Dundee
    Inventors: Dario Alessi, Muratul Muqit
  • Patent number: 8999635
    Abstract: The present invention relates to the identification of loss-of-function mutations in the filaggrin gene and their use in diagnosing ichthyosis vulgaris and/or susceptibility to other diseases including atopic dermatitis (eczema), asthma, psoriasis and allergies (including food allergy).
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: April 7, 2015
    Assignee: University Court of The University of Dundee
    Inventors: William Henry Irwin McLean, Frances Jane Dorothy Smith